Relationship Between Estrogen Receptor Status in the Primary Tumor and Its Regional and Distant Metastases: An immunohistochemical study in human breast cancer

References

• Andersen J., Ørntoft T. F., Poulsen H. S. An immunohistochemical method for demonstrating estrogen receptors in formalin fixed paraffin embedded human breast cancer tissue using a monoclonal antibody to estrophilin. J. Histo-chem. Cytochem., (In press.)
   Google Scholar
• Andersen J., Ørntoft T. F., Poulsen H. S. Semiquantitative estrogen receptor assay in formalin-fixed paraffin sections of human breast cancer tissue using monoclonal antibodies. Br. J. Cancer 1986; 53: 691
   PubMed Web of Science ®Google Scholar
• Bennett R. C., Mercer R. J., Lie T. H. Multiple or sequential oestrogen receptor assays in breast cancer. Aust. N.Z.J. Surg. 1983; 53: 231
   PubMedGoogle Scholar
• Brennan M. J., Donegan W. L., Appleby D. E. The variability of estrogen receptors in metastatic breast cancer. Am. J. Surg. 1979; 137: 260
   PubMedGoogle Scholar
• Crawford D. J., Cowan S., Fitch R., Smith D. C., Leake R. E. Stability of oestrogen receptor status in sequential biopsies from patients with breast cancer. Br. J. Cancer 1987; 56: 137
   PubMed Web of Science ®Google Scholar
• Dao T. L., Nemto T. Steroid receptors and response to endocrine ablation in women with metastatic breast cancer. Cancer 1980; 46: 2779
   PubMed Web of Science ®Google Scholar
• DeSombre E. R., Jensen E. V. Estrophilin assays in breast cancer: Quantitative features and application to mastectomy specimen. Cancer 1980; 46: 2783
   PubMed Web of Science ®Google Scholar
• DeSombre E.R., Thorpe S. M., Rose C., et al. Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer. Cancer. Res. (Suppl.) 1986; 46: 4256
   Web of Science ®Google Scholar
• Greene G. L., Jensen E. V. Monoclonal antibodies as probes for estrogen receptor detection and characterization. J. Steroid. Biochem. 1982; 16: 353
   PubMedGoogle Scholar
• Greene G.L., Nolan C., Engler J. P., Jensen E. V. Monoclonal antibodies to human estrogen receptor. Proc. Natl. Acad. Sci. USA 1980; 77: 5115
   PubMed Web of Science ®Google Scholar
• Hähnel R., Twaddle E. The relationship between estrogen receptors in primary and secondary breast carcinomas and in sequential primary breast carcinomas. Breast Cancer Res. Treat. 1985; 5: 155
   PubMed Web of Science ®Google Scholar
• Harland R. N. L., Barnes D. M., Howell A., Ribeiro G. G., Taylor J., Sellwood R. A. Variation of estrogen receptor status in cancer of the breast. Br. J. Cancer 1983; 47: 511
   PubMedGoogle Scholar
• Hawkins R. A., Black R., Steele R. J. C., Dixon J. M. J., Forrest R. J. M. Oestrogen receptor concentration in primary breast cancer and axillary node metastases. Breast Cancer Res. Treat. 1981; 1: 245
   PubMedGoogle Scholar
• Hoehn J. L., Plotka E. D., Dickson K. B. Comparison of estrogen receptor levels in primary and regional metastatic carcinoma of the breast. Ann. Surg. 1979; 190: 69
   PubMed Web of Science ®Google Scholar
• Hull D. F., III, Clark G. M., Osborne C. K., Chamness G. C., Knight W. A., III, McGuire W. L. Multiple estrogen receptor assays in human breast cancer. Cancer Res. 1983; 43: 413
   PubMed Web of Science ®Google Scholar
• Jakesz R., Smith C. A., Aitken S. Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells. Cancer Res. 1984; 44: 619
   PubMed Web of Science ®Google Scholar
• King W. J., DeSombre E. R., Jensen E. V., Greene G. L. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res. 1985; 45: 293
   PubMed Web of Science ®Google Scholar
• Klinga K., Kaufmann M., Runnebaum B., Kubli F. Distribution of estrogen and progesterone receptors on primary tumor and lymph nodes in individual patients with breast cancer. Oncology 1982; 39: 337
   PubMedGoogle Scholar
• Koenders A., Thorpe S. M. Standardization of steroid receptor assays in human breast cancer. I. Reproducibility of estradiol and progesterone receptor assays. Eur. J. Cancer Clin. Oncol. 1983; 19: 1221
   PubMedGoogle Scholar
• Leake R. E., Laing L., Calman K. C., Macbeth F. R., Crawford D., Smith D. C. Oestrogen-receptor status and endocrine therapy of breast cancer. Response rates and status stability. Br. J. Cancer 1981; 43: 59
   PubMedGoogle Scholar
• Mobbs B. G. Effect of time and therapy on the hormone receptor status of breast carcinomas. Can. Med. Assoc. J. 1982; 127: 217
   PubMedGoogle Scholar
• van Netten J. P., Algard F. T., Coy P., et al. Heterogeneous estrogen receptor levels detected via multiple microsamples from individual breast cancers. Cancer 1985; 56: 2019
   PubMed Web of Science ®Google Scholar
• Nomura Y., Tashiro H., Shinozuka K. Changes of steroid hormone content by chemotherapy and/or endocrine therapy in advanced breast cancer. Cancer 1985; 55: 546
   PubMed Web of Science ®Google Scholar
• Osborne C. K., Yochmowitz M. G., Knight W. A., III, McGuire W. L. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 1980; 46: 2884
   PubMed Web of Science ®Google Scholar
• Paridaens R., Sylvester R. J., Ferrazi E., Legros N., Leclercq G., Heuson J. C. Clinical significance of quantitative assessment of estrogen receptors in advanced breast cancer. Cancer 1980; 46: 2889
   PubMed Web of Science ®Google Scholar
• Poulsen H. S. In vitro tests and hormonal treatment of breast cancer. Prog. Surg. Path. 1983; 5: 37
   Google Scholar
• Poulsen H. S., Jensen J., Hermansen C. Human breast cancer. Heterogeneity of estrogen binding sites. Cancer 1981; 48: 1791
   PubMed Web of Science ®Google Scholar
• Raemakers J. M., Beex L. V., Koenders A.J., et al. Concordance and discordance of estrogen and progesterone receptor content in sequential biopsies of patients with advanced breast cancer. Relationship to survival. Eur. J. Cancer Clin. Oncol. 1984; 20: 1011
   PubMedGoogle Scholar
• Rose C., Thorpe S. M., Andersen K.W., et al. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet 1985; I: 16
   Google Scholar
• Rosen P. P., Menendez-Botet C. J., Urban J. A., Fracchia A., Schwartz M. K. Estrogen receptor protein (ERP) in multiple tumors specimens from individual patients with breast cancer. Cancer 1977; 39: 2194
   PubMed Web of Science ®Google Scholar
• Sebanjo R. O., Miller W. R., Hawkins R. A. Variations in steroid receptors and cyclic AMP binding proteins across human breast cancers. Evidence for heterogeneity. Br. J. Cancer 1986; 54: 127
   PubMedGoogle Scholar
• Silfverswärd C., Skoog L., Humla S., Gustafsson S. A., Nordenskjöld B. Intratumoral variation of cytoplasmatic and nuclear estrogen receptor concentrations in human mammary carcinoma. Eur. J. Cancer 1980; 16: 59
   Google Scholar
• Taylor R. E., Powles T. J., Humphreys J., et al. Effects of endocrine therapy on steroid-receptor content of breast cancer. Br. J. Cancer 1982; 45: 80
   PubMed Web of Science ®Google Scholar
• Tilley W. D., Keightley D. D., Cant E. L. M. Inter-site variation of oestrogen receptors in human breast cancers. Br. J. Cancer 1978; 38: 544
   PubMed Web of Science ®Google Scholar
• Webster D. J. T., Bronn D. G., Minton J. P. Estrogen receptor levels in multiple biopsies from patients with breast cancer. Am. J. Surg. 1978; 136: 337
   PubMedGoogle Scholar
• Weintraub J., Weintraub D., Redard M., Vassilakos P. Evaluation of estrogen receptors by immunocytochemistry on fine-needle aspiration biopsy specimens from breast tumors. Cancer 1987; 60: 1163
   PubMed Web of Science ®Google Scholar
• Williams M. R., Todd J. H., Ellis I.O., et al. Oestrogen receptors in primary and advanced breast cancer. An eight year review of 704 cases. Br. J. Cancer 1987; 55: 67
   PubMedGoogle Scholar